Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Longboard Pharmaceuticals Inc’s stock clocked out at $17.00, down -6.85% from its previous closing price of $18.25. In other words, the price has decreased by -$6.85 from its previous closing price. On the day, 0.63 million shares were traded. LBPH stock price reached its highest trading level at $18.35 during the session, while it also had its lowest trading level at $16.7.
Ratios:
To gain a deeper understanding of LBPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.14 and its Current Ratio is at 5.14. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on February 16, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On April 27, 2023, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $13.B. Riley Securities initiated its Buy rating on April 27, 2023, with a $13 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 25 ’24 when ARENA PHARMACEUTICALS INC sold 3,978,540 shares for $24.25 per share. The transaction valued at 96,479,595 led to the insider holds 0 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LBPH now has a Market Capitalization of 660929408 and an Enterprise Value of 564270208.
Stock Price History:
Over the past 52 weeks, LBPH has reached a high of $28.15, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is -16.05%, while the 200-Day Moving Average is calculated to be 48.87%.
Shares Statistics:
It appears that LBPH traded 597.79K shares on average per day over the past three months and 377570 shares per day over the past ten days. A total of 36.02M shares are outstanding, with a floating share count of 33.22M. Insiders hold about 7.78% of the company’s shares, while institutions hold 54.51% stake in the company. Shares short for LBPH as of 1711584000 were 4950405 with a Short Ratio of 8.28, compared to 1709164800 on 3185528. Therefore, it implies a Short% of Shares Outstanding of 4950405 and a Short% of Float of 18.77.
Earnings Estimates
Investors are eagerly awaiting the insights provided by Theravance Biopharma, Inc. analysts currently analyzing and rating the stock of Longboard Pharmaceuticals Inc (LBPH).The consensus estimate for the next quarter is $17.00, with high estimates of $1.00 and low estimates of $0.05.
Analysts are recommending an EPS of between $Financial Services and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
